Dermata Therapeutics Inc. (DRMA) Statistics & Valuation Metrics - Stocknear

Dermata Therapeutics Inc.

NASDAQ: DRMA · Real-Time Price · USD
5.26
-0.24 (-4.36%)
At close: Sep 05, 2025, 3:59 PM
5.35
1.77%
After-hours: Sep 05, 2025, 04:00 PM EDT

Dermata Therapeutics Statistics

Share Statistics

Dermata Therapeutics has 681.56K shares outstanding. The number of shares has increased by 322.34% in one year.

681.56K
322.34%
17.45%
38.16%
498.47K
1,224
6.35%

Short Selling Information

The latest short interest is 11.73K, so 1.72% of the outstanding shares have been sold short.

11.73K
1.72%
2.91%
1

Valuation Ratios

The PE ratio is -0.02 and the forward PE ratio is -0.95. Dermata Therapeutics's PEG ratio is 0.

-0.02
-0.95
0
0.2
0.13
-0.02
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Dermata Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.

1.79
1.79
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.54M
8
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 284.62% in the last 52 weeks. The beta is 0.56, so Dermata Therapeutics's price volatility has been higher than the market average.

0.56
284.62%
5.8
2.24
46.15
19,273

Income Statement

n/a
n/a
-12.51M
-12.29M
-12.29M
-12.29M
-80.32
Full Income Statement

Balance Sheet

The company has 3.16M in cash and 0 in debt, giving a net cash position of 3.16M.

3.16M
n/a
n/a
-65.68M
6.64M
6.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.16M and capital expenditures 0, giving a free cash flow of -11.16M.

-11.16M
n/a
-11.16M
-72.96
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

DRMA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for DRMA is $10, which is 81.8% higher than the current price. The consensus rating is "Buy".

$10
81.8%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Aug 1, 2025. It was a backward split with a ratio of 1:10.

Aug 1, 2025
backward
1:10

Scores

-16.5
1